Vasomet en es it fr

Vasomet Brand names, Vasomet Analogs

Vasomet Brand Names Mixture

  • No information avaliable

Vasomet Chemical_Formula


Vasomet RX_link

Vasomet fda sheet

Vasomet FDA

Vasomet msds (material safety sheet)

Vasomet Synthesis Reference

M. Winn et al., U.S. Pat. 4,026,894 (1977)

Vasomet Molecular Weight

387.433 g/mol

Vasomet Melting Point

273 oC

Vasomet H2O Solubility


Vasomet State


Vasomet LogP


Vasomet Dosage Forms


Vasomet Indication

For the treatment of symptomatic benign prostatic hyperplasia (BPH) and also for hypertension.

Vasomet Pharmacology

Terazosin, classified as a quinazoline, is similar to doxazosin and prazosin. As an alpha-adrenergic blocking agent, terazosin is used to treat hypertension and benign prostatic hypertrophy (BPH). Terazosin produces vasodilation and reduces peripheral resistance but in general has slight effect on cardiac output. Antihypertensive effect with chronic dosing is usually not accompanied by reflex tachycardia.

Vasomet Absorption

Essentially completely absorbed in man (90% bioavailability).

Vasomet side effects and Toxicity

LD50=259.3mg/kg (i.v. in mice)

Vasomet Patient Information

Vasomet Organisms Affected

Humans and other mammals